Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

European Commission approves Novartis' Revolade for severe aplastic anemia By PBR Staff Writer
The European Commission approved the use of Novartis' Revolade (eltrombopag) to treat patients with severe aplastic anemia (SAA) who have not responded to other treatments.
Production & Manufacturing > Manufacturing > News
Sun Pharma acquires GSK's opiates business in Australia By PBR Staff Writer
Indian drugmaker Sun Pharmaceutical Industries has acquired GlaxoSmithKline's (GSK) opiates business in Australia.
Production & Manufacturing > Manufacturing > News Novartis, Amgen collaborate on Alzheimer's and migraine treatment By PBR Staff Writer
Novartis and Amgen will work together to commercialize and develop neuroscience treatments in the areas of Alzheimer's disease (AD) and migraine.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Custom Powder Systems Announces Dramatic Yield Increase Through use of Anti-Segregation Technologies
| By Custom Powder Systems
"Our material handling process was very inefficient and we were lucky to yield 50% in-spec product" says the Director of a major generic pharmaceutical company, "and the handling labor was extensive. I can't even begin to tell you how frustrating it was." The Director is discussing the problem his company had with manufacturing one of its key products.
Production & Manufacturing > Manufacturing > White Papers
Alexion secures approvals to market two new drugs in Europe
By PBR Staff Writer
US-based Alexion Pharmaceuticals has secured approvals to market two enzyme replacement therapy drugs in Europe to treat two life-threatening conditions.
Production & Manufacturing > Manufacturing > News
Bristol-Myers secures right to buy Promedior in $1.25bn deal
By PBR Staff Writer
Bristol-Myers Squibb has secured the exclusive right to acquire Promedior and its fibrosis drug for about $1.25bn.
Production & Manufacturing > Manufacturing > News
Agile completes patient recruitment in Twirla phase 3 SECURE clinical trial
By PBR Staff Writer
Agile Therapeutics has completed patient recruitment in phase 3 SECURE clinical trial of Twirla (AG200-15) investigational contraceptive patch.
Production & Manufacturing > Manufacturing > News
Sucampo launches tender to buy R-Tech Ueno for $278m
By PBR Staff Writer
US-based Sucampo Pharmaceuticals has launched an all-cash tender offer through its Japanese subsidiary to acquire Japan-based pharmaceutical company R-Tech Ueno for around JPY33bn ($278m).
Production & Manufacturing > Manufacturing > News
Celgene strengthens I&I portfolio with $7.2bn Receptos acquisition
By PBR Staff Writer
US-based biotechnology firm Celgene has expanded its inflammation and immunology (I&I) portfolio with the acquisition of Receptos for around $7.2bn.
Production & Manufacturing > Manufacturing > News
Novo Nordisk to invest $2bn in new manufacturing facilities in US and Denmark
By PBR Staff Writer
Danish drugmaker Novo Nordisk is planning to invest $2bn over the next five years to build new production facilities in Clayton, US and Måløv, Denmark, to meet the increasing demand for its diabetes medicines across the world.
Production & Manufacturing > Manufacturing > News
Shire to secure improved Cinryze manufacturing flexibility and capacity
By PBR Staff Writer
Irish biopharmaceutical firm Shire has entered into an agreement with Sanquin Blood Supply for Cinryze (C1 esterase inhibitor [human]), which is used for the prophylactic treatment of hereditary angioedema (HAE).
Production & Manufacturing > Manufacturing > News
Mylan introduces Piperacillin and Tazobactam for injection in US
By PBR Staff Writer
Mylan has launched Piperacillin and Tazobactam for injection USP, 3.375g single-dose vials in the US to treat patients with moderate to severe infections caused by susceptible isolates of certain bacteria.
Production & Manufacturing > Manufacturing > News
Oncodrone gets EUR2.5m Eurostars grant to develop prostate cancer drug OCD155
By PBR Staff Writer
Dutch anti-cancer firm Oncodrone has secured a EUR2.5m Eurostars grant to develop its lead drug OCD155 to treat prostate cancer.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests